Combined Immunodeficiency Due to GINS1 Deficiency

Combined immunodeficiency due to GINS1 deficiency is a very rare genetic disease that weakens the immune system from birth. “Combined immunodeficiency” means that more than one part of the immune system does not work well, especially infection-fighting white blood cells. In this condition, children usually have poor growth before birth and after birth, a long-lasting low neutrophil count (neutropenia), and a very low number or poor function of natural killer (NK) cells. These cells are important to fight bacteria and viruses. The problem comes from harmful changes (mutations) in a gene called GINS1, which is needed for normal DNA copying and cell division. When this gene does not work well, bone marrow cells cannot grow and mature properly, so the body cannot make enough healthy immune cells. [1]

Combined immunodeficiency due to GINS1 deficiency is a very rare, inherited immune system disease. It is also called immunodeficiency-55 (IMD55) or combined immunodeficiency with intra-uterine growth retardation, NK-cell deficiency and neutropenia. Children are usually small before birth and after birth, have very low neutrophils, very low natural killer (NK) cells and recurrent serious infections from early life. [1]

The problem starts in the GINS1 gene, which encodes a protein that is part of the GINS complex, a core component of the DNA-replication machinery in all dividing cells. When GINS1 is not working properly, bone-marrow cells cannot replicate their DNA and divide normally. This leads to poor production and maturation of immune cells, especially NK cells, neutrophils and T-cells, which together cause a combined immunodeficiency picture. [2]

Because this disease is so rare, almost all information comes from a small number of families and research studies. Doctors describe it as an autosomal recessive primary immunodeficiency, which means a child usually needs to inherit one faulty copy of the gene from each parent. The disease is also known as Immunodeficiency-55 (IMD55) in some medical systems. [2]

---

Other names

Doctors and databases use several names for the same condition. All of these describe the same basic disease caused by GINS1 gene changes. Common names include:

• Combined immunodeficiency due to GINS1 deficiency

• CID due to GINS1 deficiency

• Immunodeficiency-55 (IMD55)

• Combined immunodeficiency with intrauterine growth retardation–NK cell deficiency–neutropenia

• Combined immunodeficiency with intrauterine growth retardation–natural killer cell deficiency–neutropenia

These names highlight three key features: poor growth in the womb (intrauterine growth retardation), chronic neutropenia, and natural killer cell deficiency, all due to mutations in the GINS1 gene on chromosome 20. [3]

---

Types

There is no official “type 1, type 2, type 3” system for this disease, because only a few patients have been reported worldwide. However, researchers notice some patterns that can be used as descriptive types to help understand how the condition can look in different children: [4]

1. Partial GINS1 deficiency – Some children have mutations that allow a small amount of GINS1 protein to remain. DNA replication is reduced but not completely stopped. These patients may have milder growth problems and infections compared with more severe cases.

2. More severe GINS1 deficiency – Other mutations cause a stronger loss of GINS1 function. These children often have more serious growth delay and more obvious immune problems, because DNA replication is more strongly affected.

3. Homozygous mutation form – The child inherits the same faulty GINS1 variant from both parents. This pattern is called “homozygous” and is common in families where the parents are related (consanguineous families).

4. Compound heterozygous form – The child inherits two different faulty GINS1 variants, one from each parent. The combined effect of these two variants still causes GINS1 deficiency and immunodeficiency.

5. Growth-dominant phenotype – In some children, the most striking signs are very small size before birth and severe postnatal growth failure, while infections might be relatively fewer but still present.

6. Infection-dominant phenotype – In others, the repeated infections, neutropenia, and NK-cell deficiency are more prominent than the growth problems.

These “types” are descriptive and based on how the disease looks and on genetic test results. They are not formal categories in classification systems, but they help doctors think about severity and variation. [5]

---

Causes

The main cause is always harmful mutations in the GINS1 gene. The list below breaks this main cause into smaller, easy-to-understand pieces showing how and why problems happen.

1. Homozygous GINS1 gene mutations
   When a child receives the same faulty copy of the GINS1 gene from both parents, the GINS1 protein cannot work properly. This strong loss of function blocks normal DNA replication in bone marrow cells and leads to combined immunodeficiency. [6] [7]

2. Compound heterozygous GINS1 mutations
   Some children carry two different GINS1 mutations, one on each copy of the gene. Each variant damages the protein in a slightly different way, but together they lower GINS1 activity to a critical level, again disturbing immune cell development. [8]

3. Loss-of-function variants (nonsense or frameshift)
   Certain mutations introduce a “stop” signal too early or shift the reading frame of the gene. These changes can produce a truncated or unstable protein that is quickly destroyed, leaving cells almost without usable GINS1. [9]

4. Missense variants (single amino acid changes)
   Other mutations change one building block (amino acid) in the GINS1 protein. Even a small change in a key region can make the protein fold incorrectly or fail to join the other GINS complex subunits, reducing its function but not fully eliminating it. [10]

5. Failure of the GINS complex assembly
   GINS1 is one of four proteins in the GINS complex (with GINS2, GINS3, GINS4). This complex is essential for starting and continuing DNA replication. When GINS1 is faulty, the whole complex may not assemble or stay stable, so replication forks cannot progress normally. [11]

6. Defective DNA replication in rapidly dividing immune cells
   Immune cells in the bone marrow divide quickly. If DNA replication is slow or incomplete because of GINS1 deficiency, these cells cannot divide and mature as they should. This leads to low numbers of neutrophils and NK cells in the blood. [12]

7. Bone marrow differentiation block
   Studies of patients show a “block” at certain stages of neutrophil and NK cell development in the bone marrow. Immature cells cannot move to the next step because they cannot replicate their DNA properly, so they die or remain stuck. [13]

8. Autosomal recessive inheritance from carrier parents
   Parents usually carry one normal and one mutated GINS1 gene and are healthy. When both parents are carriers, each pregnancy has a 25% chance of producing a child with two mutated copies and therefore with the disease. This is the classic autosomal recessive pattern. [14]

9. Consanguinity (parents related by blood)
   In families where the parents are cousins or otherwise related, the chance of inheriting the same rare faulty gene from both sides is higher. Consanguinity has been reported in several inborn errors of immunity, including GINS1 deficiency and similar conditions. [15]

10. De novo GINS1 mutation in the child
    In rare cases, a new mutation may appear in the child’s GINS1 gene that is not present in the parents. This “de novo” event can still cause the same disease, although it has been less commonly described. [16]

11. Regulatory or splice-site variants
    Some mutations may lie in non-coding parts of the gene, such as introns or promoter regions. These changes can affect how much GINS1 mRNA is made or how it is spliced, leading to lower protein levels and partial deficiency. [17]

12. Cell cycle checkpoint stress
    When DNA replication is faulty, cell cycle checkpoints are activated to protect cells from copying damaged DNA. In GINS1 deficiency, repeated activation of these checkpoints can cause bone marrow cells to stop dividing or to die, worsening neutropenia and NK cell deficiency. [18]

13. Increased apoptosis (cell death) of progenitor cells
    DNA replication stress can trigger programmed cell death (apoptosis) in early immune cell precursors. This means fewer cells survive long enough to mature into working neutrophils and NK cells. [19]

14. Intrauterine growth impairment
    GINS1 is needed in many tissues, not just the immune system. When it is deficient, cell division is reduced throughout the developing fetus, leading to poor growth in the womb and low birth weight. [20]

15. Postnatal growth failure
    After birth, children with GINS1 deficiency still have problems with cell division in many organs. This can cause continued poor weight gain and short stature, which are part of the disease picture. [21]

16. Co-existing variants in other immune genes (possible modifiers)
    Some patients with inborn errors of immunity also carry variants in other genes that can make the disease milder or more severe. For GINS1 deficiency, researchers suggest that other genetic backgrounds may slightly change how serious the infections and growth problems are. [22]

17. Environmental triggers revealing the defect
    The genetic problem is present from birth, but environmental factors such as early viral or bacterial infections can reveal the immune weakness. Children may first come to medical attention after unusual or repeated infections. [23]

18. Founder effect in certain families or populations
    In some rare diseases, the same GINS1 mutation appears in several related families due to a “founder” ancestor who first carried the variant. This can cluster cases in specific regions or communities. [24]

19. Persistent neutropenia from impaired bone marrow output
    Continuous low production of neutrophils from the bone marrow leads to chronic neutropenia. This is not due to destruction of neutrophils in the blood, but mainly due to poor release of mature cells from the marrow. [25]

20. Natural killer cell deficiency from blocked NK development
    The same DNA replication defect affects the pathway that makes NK cells. As a result, NK cells are very low or absent, or they function poorly. NK cell deficiency makes patients more sensitive to certain viral infections and possibly some cancers. [26]

---

Symptoms

Not every patient will have all of these symptoms, but the list shows common or possible features described in reported cases and in related immunodeficiency literature.

1. Intrauterine growth retardation (small baby before birth)
   Many affected babies are much smaller than expected during pregnancy and at birth. Ultrasound scans may show poor growth, and birth weight is often low. This happens because cells throughout the fetus do not divide normally when GINS1 is deficient. [27]

2. Postnatal growth retardation (poor growth after birth)
   After birth, children frequently continue to grow slowly, with short stature and low weight for age. Even with good nutrition, height and weight curves may stay below normal lines on the growth chart. [28]

3. Chronic neutropenia
   A constant low neutrophil count is a major sign. Routine blood tests often show neutrophils well below the normal range, even when the child looks well. This chronic neutropenia increases the risk of bacterial infections, especially of the skin, lungs, and mouth. [29]

4. Natural killer (NK) cell deficiency
   NK cells are part of the innate immune system and help to kill virus-infected and cancer cells. In GINS1 deficiency, NK cells may be almost absent or have poor function. This is an important clue that points doctors toward this rare diagnosis. [30]

5. Recurrent bacterial infections
   Children may suffer repeated bacterial infections such as pneumonia, skin abscesses, ear infections, or sepsis. Because neutrophils are low, infections can be more frequent or last longer than usual and may need hospital treatment and intravenous antibiotics. [31]

6. Recurrent viral infections
   NK-cell deficiency can lead to repeated or unusually severe viral infections, especially from herpesviruses such as herpes simplex, varicella-zoster (chickenpox), or cytomegalovirus. These infections may heal slowly or keep coming back. [32]

7. Dry or eczematous skin
   Many patients have very dry skin or eczema-like rashes. The skin barrier may be weaker, and repeated infections or inflammation can make the skin itchy, red, and scaly. [33]

8. Mild facial differences (dysmorphism)
   Some children show mild facial features, such as a small chin, high forehead, or other subtle differences. These do not harm the child but can help doctors recognize a specific syndrome pattern together with growth and immune problems. [34]

9. Frequent fevers
   Because the immune system is weak, the body often reacts to infections with fever. Sometimes fever may be the only visible sign at first, while typical infection signs may be mild because neutrophils are low. [35]

10. Mouth ulcers and gum infections
    Chronic neutropenia commonly causes painful mouth ulcers, bleeding gums, and frequent dental infections. These problems can interfere with eating and may worsen poor weight gain. [36]

11. Recurrent chest infections and cough
    Repeated pneumonia or bronchitis is a typical sign of primary immunodeficiency. Over time, if not well treated, lung damage such as bronchiectasis can occur, so early recognition and treatment are important. [37]

12. Enlarged lymph nodes or spleen (in some patients)
    Because the immune system is constantly fighting infections, lymph nodes or the spleen may become enlarged. This is not reported in all GINS1 cases but is common in many primary immunodeficiencies and can appear in some children with chronic infections. [38]

13. Fatigue and low energy
    Children with repeated infections and chronic inflammation may feel tired, less active, and less able to play than their peers. Poor sleep, anemia, or chronic illness can all contribute to this tired feeling. [39]

14. Delayed developmental milestones (in severe or chronic illness)
    Serious and frequent illness, hospital stays, and poor nutrition can sometimes delay motor or social milestones. This is usually secondary to the chronic disease rather than directly caused by the gene itself. [40]

15. Psychological and family stress
    Living with a rare immunodeficiency can cause worry, stress, and anxiety for the child and family. Fear of infections, repeated hospital visits, and uncertainty about the future can all affect mental health and quality of life. [41]

---

Diagnostic tests

Diagnosis needs a specialist team (usually pediatric immunologists and geneticists). Tests try to:

Physical examination

1. Detailed growth and nutrition examination
   The doctor measures weight, height, and head size and plots them on growth charts over time. Falling far below the normal lines or very slow growth suggests growth retardation, a hallmark feature of GINS1 deficiency and similar DNA-replication-related immunodeficiencies. [42]

2. Skin examination
   The doctor looks carefully at the skin for eczema, dryness, rashes, or signs of infection such as boils or abscesses. Persistent eczema or unusual recurrent skin infections raise suspicion of an underlying immune problem. [43]

3. Facial and general physical inspection
   Mild facial differences, limb proportions, posture, and general appearance are examined. The doctor looks for patterns that point to a specific syndrome, including the facial features described in cases of immunodeficiency-55. [44]

4. Lung and heart examination
   Using a stethoscope, the doctor listens to the lungs for crackles or wheezes and to the heart for murmurs. Recurrent pneumonia, chronic cough, or reduced breath sounds suggest repeated chest infections, which are important clues in primary immunodeficiency. [45]

5. Abdominal and lymph node examination
   The abdomen is felt to check for an enlarged liver or spleen, and neck, armpit, and groin are checked for enlarged lymph nodes. These findings can appear with chronic infections and some immunodeficiencies and help guide further tests. [46]

Manual / bedside clinical tests

6. Developmental and functional assessment
   The doctor, sometimes with a physiotherapist, evaluates how the child moves, plays, and communicates compared with age-matched peers. This helps to understand if long-term illness has affected physical or social development and gives a baseline for future care. [47]

7. Temperature and vital sign monitoring
   Repeated measurement of temperature, heart rate, breathing rate, and oxygen level during and between infections helps to judge how serious infections are and guides urgent treatment decisions. [48]

8. ENT and oral cavity examination
   The doctor examines the ears, nose, throat, teeth, and gums for chronic otitis media, sinusitis, tonsillitis, or periodontal disease. These frequent ENT and oral infections are typical in many primary immunodeficiencies and in chronic neutropenia. [49]

9. Family history and pedigree analysis
   A careful history of relatives with severe infections, early childhood deaths, or similar symptoms is taken, and a family tree is drawn. Patterns of affected and unaffected members can suggest autosomal recessive inheritance and help decide when to order genetic tests. [50]

10. Simple exercise tolerance observation
    Doctors may observe how easily the child becomes tired when walking or playing, and whether they cough or breathe fast with small efforts. Poor tolerance can reflect chronic lung disease or general weakness from long-lasting illness. [51]

Laboratory and pathological tests

11. Complete blood count (CBC) with differential
    CBC is usually the first key test. It measures total white blood cells and counts each type, including neutrophils, lymphocytes, monocytes, eosinophils, and basophils. In GINS1 deficiency, chronic neutropenia is common, and sometimes other cell lines can also be affected. [52]

12. Peripheral blood smear
    A drop of blood is examined under a microscope to look at the shape and maturity of white cells, red cells, and platelets. This can show whether bone marrow is producing cells abnormally and helps distinguish between different causes of neutropenia and immunodeficiency. [53]

13. Lymphocyte subset analysis by flow cytometry (T, B, NK cells)
    Flow cytometry uses fluorescent antibodies to count T cells, B cells, and NK cells. In GINS1 deficiency, NK cells are often very low or absent, while T and B cell counts may be relatively preserved. This pattern (chronic neutropenia plus NK-cell deficiency) is a strong diagnostic clue. [54]

14. Serum immunoglobulin levels (IgG, IgA, IgM, IgE)
    Measuring immunoglobulin (antibody) levels helps to see how well B cells are functioning. Some patients with inborn errors of immunity have low or abnormal immunoglobulin levels, which can contribute to recurrent infections. In GINS1 deficiency, this test is part of the general PID work-up. [55]

15. NK cell functional (cytotoxicity) assays
    Special laboratory tests check whether NK cells can kill target cells in vitro. Even if a few NK cells are present, their killing function may be poor. Combining NK-cell counts and function tests gives a detailed picture of NK-cell deficiency. [56]

16. Bone marrow aspirate and biopsy
    A bone marrow sample from the hip bone is examined under the microscope and sometimes with flow cytometry and genetic tests. In chronic neutropenia due to bone marrow failure, doctors may see a block in neutrophil and NK-cell maturation, helping to support the diagnosis of a replication-related defect like GINS1 deficiency. [57]

17. Targeted genetic testing or whole-exome sequencing for GINS1
    Genetic testing looks for mutations in genes known to cause primary immunodeficiency or chronic neutropenia. When clinical and laboratory findings suggest GINS1 deficiency, sequencing of the GINS1 gene (or broader exome sequencing) can confirm homozygous or compound heterozygous pathogenic variants and establish the final diagnosis. [58]

Electrodiagnostic tests

18. Electrocardiogram (ECG) or EEG in selected cases
    Electrodiagnostic tests like ECG (for heart rhythm) or EEG (for brain activity) are not routine for diagnosing GINS1 deficiency itself. However, they may be used if severe infections affect the heart or brain, or if medicines used to treat infections might disturb heart rhythm. In this context they are supportive safety tests, not primary diagnostic tools for the immunodeficiency. [59]

Imaging tests

19. Chest X-ray
    A plain chest X-ray is often used when a child has cough, fever, or breathing problems. It can show pneumonia, lung collapse, or chronic lung changes. Repeated abnormal chest X-rays in a child with neutropenia and NK-cell deficiency support the suspicion of an underlying primary immunodeficiency. [60]

20. High-resolution CT (HRCT) or MRI in complicated cases
    When chest X-rays or clinical findings suggest long-term lung damage, CT scans can show details like bronchiectasis, scarring, or structural lung problems. MRI or CT of other body parts can also detect deep infections or organ damage. These imaging studies do not diagnose GINS1 deficiency directly, but they show how much the disease has affected organs. [61]

Non-pharmacological treatments

1. Protective infection-control lifestyle – Families are taught careful hand washing, mask use during outbreaks, avoiding sick contacts and crowded places, and cleaning frequently touched surfaces. This reduces exposure to common viruses and bacteria, which is critical when neutrophils and NK cells are very low. [5]

2. Household vaccination strategy – Parents, siblings and caregivers receive all recommended inactivated vaccines (including influenza and COVID-19) to create a “cocoon” of protection around the child. Live vaccines are avoided for the patient but can often be safely given to healthy contacts according to specialist advice. [6]

3. Avoidance of live vaccines in the patient – Because T-cell and NK-cell function is impaired, live vaccines such as measles, mumps, rubella, oral polio or BCG can cause disease instead of protection. Immunologists typically delay or avoid all live vaccines until after successful HSCT and immune reconstitution. [7]

4. Prompt fever and infection action plan – Parents are given a written plan: check temperature, call the hospital immediately, and come directly for urgent antibiotics if a fever or new infection appears. Early recognition and rapid treatment help prevent sepsis in neutropenic patients. [8]

5. Nutritional optimization – A dietitian designs high-calorie, high-protein, micronutrient-rich meal plans to combat growth failure and support immune cell production. In some children, tube feeding or specialized formulas are needed to maintain weight and improve wound healing and infection recovery. [9]

6. Oral and dental hygiene program – Gentle brushing, fluoride use, regular dental checks and prompt treatment of mouth ulcers or gingivitis reduce the risk of bacteremia and sepsis from oral sources, a common risk in neutropenia and combined immunodeficiency. [10]

7. Skin and catheter care – Daily inspection of skin, careful care of central venous lines, and avoidance of unnecessary invasive procedures lower infection risk. Families are taught to recognize redness, pus or swelling early at any catheter or injection site. [11]

8. Respiratory physiotherapy and airway hygiene – Chest physiotherapy, breathing exercises and sometimes home suction devices help clear secretions, especially after pneumonia. Good airway hygiene reduces chronic lung damage from recurrent infections. [12]

9. Environmental mold and dust control – For children with severe immunodeficiency, simple measures such as avoiding damp rooms, removing visible mold, and using HEPA filters during construction or renovation can lower fungal exposure, which is important because invasive fungal infections are a major cause of death in SCID-like conditions. [13]

10. School and social adaptations – Many children benefit from home-based schooling, smaller classroom settings or flexible attendance during winter. This balances infection prevention with healthy social and cognitive development, which is vital for long-term quality of life. [14]

11. Psychological support for family – Living with a rare, life-threatening condition is emotionally exhausting. Access to psychologists, social workers and peer-support groups reduces anxiety and depression, improves adherence to complex treatment plans and supports informed decision-making about HSCT. [15]

12. Genetic counselling – Families receive clear explanations of autosomal-recessive inheritance, carrier testing and recurrence risk. This helps them plan future pregnancies, consider prenatal or pre-implantation diagnosis and inform extended relatives who may also be carriers. [16]

13. Infection-control training for local healthcare teams – Local doctors and nurses are educated about the child’s immune status, need for rapid antibiotics and avoidance of live vaccines, so that emergency visits and routine care are handled safely, even outside specialist centers. [17]

14. Regular comprehensive follow-up visits – Scheduled visits with immunology and hematology teams include growth checks, infection review, lung function assessment and bone-marrow monitoring, so changes in disease course are detected early and treatments can be adjusted. [18]

15. Home monitoring tools – Families may be taught to use thermometers, pulse oximeters and symptom diaries. Simple home monitoring helps identify deterioration early and gives objective information to doctors during telemedicine calls or emergency triage. [19]

16. Telemedicine and shared-care models – Because GINS1 deficiency is extremely rare, care is often coordinated by a distant reference center. Teleconsultations and shared guidelines help local hospitals deliver consistent care while enabling rapid specialist input during crises. [20]

17. Pre-HSCT conditioning education – Before stem-cell transplant, families are counselled about isolation, chemotherapy conditioning, graft-versus-host disease and long-term follow-up. Good preparation improves adherence, reduces fear and helps them recognize complications early. [21]

18. Physiotherapy and gentle exercise – Tailored exercise maintains muscle strength, lung capacity and bone health, which are often affected by malnutrition and chronic illness. Activity plans are adjusted to energy levels and infection status. [22]

19. Fertility and long-term health counselling (older patients) – Survivors of HSCT or long-term immunosuppression may face fertility issues, secondary cancers or endocrine problems. Early counselling and screening plans help detect and manage these late effects. [23]

20. Palliative and supportive care when needed – In very severe cases where HSCT is not possible or fails, palliative care teams focus on symptom relief, comfort, and family support while still preventing and treating infections as appropriate. [24]

---

Drug treatments

These medicines are used for infection prevention, infection treatment and bone-marrow support in SCID-like and neutropenic conditions; they are not specific “cures” for GINS1 deficiency and must be chosen and dosed only by specialists.

1. Intravenous immunoglobulin (IVIG) – Human pooled antibodies given IV every 3–4 weeks replace missing antibodies and help prevent bacterial and viral infections. Several IVIG products are approved for primary immune deficiency and other indications in FDA labeling, with weight-based dosing adjusted to infection history and IgG levels. [25]

2. Subcutaneous immunoglobulin (SCIG) – SCIG provides the same antibodies in smaller weekly or bi-weekly doses at home. It offers more stable IgG levels and fewer systemic reactions for some patients, and is approved for primary immunodeficiency in FDA orphan-drug listings. [26]

3. Filgrastim (G-CSF, e.g., NEUPOGEN, biosimilars) – Filgrastim is a granulocyte colony-stimulating factor that boosts neutrophil production. FDA labels describe SC or IV doses starting around 5 mcg/kg/day in chemotherapy-induced neutropenia, titrated to absolute neutrophil count; similar principles are adapted for chronic congenital neutropenia. Main side effects include bone pain and splenomegaly. [27]

4. Pegfilgrastim and other long-acting G-CSF products – Pegfilgrastim and related biosimilars provide longer-lasting neutrophil stimulation, so they can be given less often. FDA labels support their use after chemotherapy and in severe chronic neutropenia, with dosing usually once per chemotherapy cycle or every few weeks and similar bone-pain and splenic risks. [28]

5. Trimethoprim-sulfamethoxazole (TMP-SMX; BACTRIM / SEPTRA) – TMP-SMX is the cornerstone drug for Pneumocystis jirovecii pneumonia prophylaxis in many primary immunodeficiencies. FDA labels describe weight-based prophylactic regimens (for example one double-strength tablet daily in adults) with common side effects such as rash, cytopenias and renal effects. [29]

6. Broad-spectrum IV antibiotics (e.g., piperacillin-tazobactam) – During febrile neutropenia, broad IV antibiotics are given immediately to cover gram-negative and gram-positive bacteria. Doses are weight-based and adapted to kidney function and local resistance patterns; this practice is standard in SCID and severe neutropenia protocols. [30]

7. Oral step-down antibiotics (e.g., amoxicillin-clavulanate, cephalosporins) – Once the patient is stable, oral agents can complete treatment or provide prophylaxis after severe infections. The choice depends on culture results, prior drug exposure and organ function, again guided by general SCID management recommendations. [31]

8. Azithromycin or other macrolides – Macrolides may be used as additional prophylaxis against respiratory bacteria or atypical organisms, especially in patients with chronic lung disease. They also have mild anti-inflammatory effects but can prolong QT interval and interact with other medicines. [32]

9. Antifungal prophylaxis with posaconazole (NOXAFIL) – Posaconazole is a broad-spectrum triazole antifungal approved for prophylaxis in severely immunocompromised patients. FDA labels describe oral suspension, tablets and IV forms with dosing linked to weight and food intake, and warn about liver enzyme elevation and major drug interactions. [33]

10. Other triazoles (e.g., fluconazole) or echinocandins – Depending on risk profile and local practice, fluconazole or echinocandins like micafungin may be chosen for yeast prophylaxis or treatment. They are used according to their FDA-approved indications for invasive fungal infections in neutropenic or transplant patients. [34]

11. Acyclovir or valacyclovir – These antivirals help prevent or treat herpes simplex and varicella-zoster infections, which can be severe in combined immunodeficiency. Doses are adjusted to kidney function, and labels warn about crystalluria and neurotoxicity at high doses. [35]

12. Ganciclovir or valganciclovir – In patients with cytomegalovirus (CMV) infection or post-transplant risk, ganciclovir-based regimens are used. They target viral DNA polymerase but can cause bone-marrow suppression, which is particularly important in someone who is already cytopenic. [36]

13. Broad-spectrum antivirals or monoclonal antibodies during outbreaks – Depending on regional guidance, agents such as ribavirin for severe RSV or specific monoclonal antibodies for respiratory viruses may be considered, particularly before or after HSCT to prevent life-threatening pneumonia. [37]

14. Prophylactic azoles or other drugs around HSCT – After HSCT, complex prophylactic regimens often combine antibacterial, antifungal and antiviral agents according to transplant protocols to protect the new immune system while it is engrafting. [38]

15. Antipyretics such as acetaminophen – Paracetamol is used symptomatically for fever and discomfort. It does not treat infection but improves comfort and may help maintain hydration; labels stress liver-dose limits, especially when multiple drugs are used. [39]

16. Antiemetics and gastro-protection around chemotherapy/HSCT – Agents such as ondansetron and proton-pump inhibitors protect from nausea and gastric injury during conditioning regimens. This improves nutritional intake and tolerability of curative therapy. [40]

17. Calcineurin inhibitors and other immunosuppressants post-HSCT – Drugs such as cyclosporine or tacrolimus are used to prevent graft-versus-host disease after allogeneic HSCT. They are carefully balanced with infection-prevention strategies to avoid excessive immunosuppression. [41]

18. Prophylactic anticoagulation when indicated – Some very ill patients or those with central lines may receive low-dose anticoagulants to prevent clots. This is individualized and monitored closely because thrombocytopenia and bleeding risk are common. [42]

19. Electrolyte and micronutrient replacement – Intravenous or oral replacement of electrolytes, iron, folate and trace elements is not disease-specific but is essential supportive drug therapy to maintain organ function and support hematopoiesis, especially during prolonged hospital stays. [43]

20. Specialized treatments for complications – Depending on the child, additional labeled medicines may be used, such as pulmonary vasodilators for pulmonary hypertension or anti-epileptics for seizures. These are chosen based on standard indications but always with infection risk and marrow reserve in mind. [44]

---

Dietary molecular supplements

1. High-quality protein (whey, casein, amino-acid formulas) – Medical nutrition formulas rich in essential amino acids provide building blocks for immune cells and tissues. They help correct protein-energy malnutrition that worsens infection risk. Dosing is tailored to age, kidney and liver function. [45]

2. Vitamin D – Vitamin D helps regulate innate and adaptive immunity and supports bone health, which is important in chronically ill children and after HSCT. Supplement doses depend on baseline levels but must avoid toxicity; monitoring 25-OH vitamin D is recommended. [46]

3. Omega-3 fatty acids – EPA and DHA from fish oil have anti-inflammatory properties and may help modulate excessive inflammation during infections. They are usually given in standard pediatric doses but must be monitored for gastrointestinal upset and bleeding risk at higher doses. [47]

4. Zinc supplementation – Zinc is crucial for lymphocyte function and wound healing. In children with poor diets or chronic diarrhea it is often low; replacement within recommended daily allowances can improve infection outcomes but high doses may interfere with copper metabolism. [48]

5. Iron, folate and vitamin B12 – These micronutrients support hemoglobin and DNA synthesis. Deficiency can worsen anemia and immune dysfunction; supplementation is guided by blood tests and adjusted to avoid iron overload or masking B12 deficiency. [49]

6. Probiotic foods or carefully selected probiotic products – Under specialist guidance, some centers use non-pathogenic probiotic strains to support gut barrier function, but in severe immunodeficiency this must be weighed against the rare risk of probiotic-related sepsis. [50]

7. Glutamine-enriched feeds – Glutamine is a fuel for rapidly dividing cells in the gut and immune system. In some critical-care and HSCT settings, glutamine-enriched nutrition is explored to support mucosal integrity, although evidence is mixed and doses must be individualized. [51]

8. Antioxidant vitamins (C and E) – These vitamins help control oxidative stress during severe infections and after chemotherapy. They are usually given at standard dietary allowance doses, because very high doses could interfere with some treatments or cause side effects. [52]

9. Medium-chain triglyceride (MCT)-rich formulations – In patients with malabsorption, MCT-based formulas provide calories that are easier to absorb. Better energy intake supports growth and immune function. Dosing is adjusted to avoid diarrhea or discomfort. [53]

10. Lactose-free or hypoallergenic formulas when needed – After gut infections or in children with food protein intolerance, specialized formulas reduce symptoms and improve nutrient absorption, which indirectly supports immune defence. [54]

---

Immunity-booster, regenerative and stem-cell-related drugs

1. Granulocyte colony-stimulating factors (G-CSF, e.g., filgrastim) – G-CSF drugs directly stimulate bone-marrow precursors to produce neutrophils, partially correcting chronic neutropenia and lowering bacterial infection risk in some patients, according to FDA-approved indications for severe chronic neutropenia and chemotherapy-induced neutropenia. [55]

2. Long-acting G-CSF (pegfilgrastim and biosimilars) – These agents work like filgrastim but remain in the body longer, allowing less frequent dosing while sustaining neutrophil counts. They support marrow regeneration after chemotherapy and HSCT, though careful monitoring for bone pain and rare splenic rupture is required. [56]

3. Hematopoietic stem-cell grafts (as a “living drug”) – The donor stem-cell product used in HSCT is often described as a living cell therapy. It replaces the patient’s defective immune system with donor cells capable of normal DNA replication and immune function, and is considered the only established curative treatment for SCID-type conditions. [57]

4. Cytokine support (e.g., GM-CSF in selected cases) – In special situations, other growth factors such as granulocyte-macrophage colony-stimulating factor (GM-CSF) can be used to broaden stimulation of myeloid cells. This is off-label and reserved for expert centers because of inflammatory side effects. [58]

5. Post-transplant immune-modulating therapies – After HSCT, short-term immunosuppressants (calcineurin inhibitors) and sometimes biologics are used to control graft-versus-host disease while the new immune system regenerates. Proper balancing of these agents supports long-term graft survival and immune reconstitution. [59]

6. Experimental gene-therapy vectors (research setting) – For some forms of SCID, viral vectors deliver a correct copy of the disease gene into the patient’s own stem cells. For GINS1 deficiency this is still experimental, but the principle shows how regenerative, gene-correcting therapies may become future options. [60]

---

Surgeries and major procedures

1. Allogeneic hematopoietic stem-cell transplantation (HSCT) – HSCT infuses donor bone-marrow or peripheral blood stem cells after conditioning chemotherapy. The goal is to rebuild the patient’s immune and blood-forming system with healthy donor cells and provide a long-term cure for the immunodeficiency. [61]

2. Central venous catheter insertion – A tunneled central line or port is often required to give IVIG, antibiotics, chemotherapy and blood products repeatedly. It reduces the trauma of repeated needle sticks but must be inserted and cared for carefully to avoid line-related infections. [62]

3. Granulocyte transfusions (in special situations) – In life-threatening, drug-resistant infections with very low neutrophil counts, granulocyte transfusions from donors may be used as a rescue procedure. This is technically demanding and used rarely, but it can temporarily boost neutrophil numbers. [63]

4. Lung or sinus surgery for structural damage – Repeated infections can cause bronchiectasis or chronic sinus disease. In selected cases, surgery removes badly damaged tissue or improves drainage to lower future infection risk and improve breathing. [64]

5. Supportive procedures (feeding tubes, tracheostomy) – Feeding tubes help maintain nutrition in children with severe swallowing problems or chronic diarrhea; tracheostomy may be needed for long-term ventilation in extreme cases. These procedures are done to protect airway, lungs and nutrition when conservative measures fail. [65]

---

Prevention and lifestyle measures

1. Keep strict hand hygiene and avoid close contact with sick people, especially during cold and flu seasons. [66]

2. Ensure all household members are fully vaccinated with inactivated vaccines, including influenza and COVID-19, as recommended by the immunology team. [67]

3. Do not give the patient any live vaccines unless a specialist confirms that immune recovery after HSCT makes them safe. [68]

4. Have a written emergency plan for fevers and infections, including which hospital to attend and which doctors to call. [69]

5. Attend all scheduled clinic visits and laboratory monitoring appointments so that problems are caught early. [70]

6. Follow nutritional advice carefully to maintain a healthy weight and good micronutrient status. [71]

7. Keep the home environment clean, dry and free from mold or heavy dust, especially in bedrooms and living areas. [72]

8. Avoid smoking or vaping in the home or near the child, as this damages airway defences. [73]

9. Discuss travel plans with the immunology team well in advance to plan extra precautions or prophylactic medicines. [74]

10. Seek psychological and social support for the whole family to reduce stress and improve adherence to complex long-term treatment. [75]

---

When to see doctors

Families should stay in very close contact with their immunology and transplant teams. Any fever, breathing difficulty, new cough, severe diarrhea, vomiting, reduced feeding, unusual rash, sudden fatigue or behavior change should trigger urgent medical review, because infections can progress much faster in combined immunodeficiency and neutropenia than in healthy children. [76]

You should also seek urgent care if there is pain, redness or discharge around a central line, surgery wound or injection site, or if the child is unusually sleepy, confused or has seizures. These can be signs of serious bacterial, fungal or viral infection or central nervous system involvement, which require immediate hospital treatment with IV medicines. [77]

Regularly scheduled visits with the immunologist or transplant team are equally important, even when the child seems “well”. These visits allow doctors to track growth, blood counts, immunoglobulin levels and lung function, and to decide the right timing for HSCT or other major interventions. Missing visits can delay important decisions about curative treatment. [78]

---

What to eat and what to avoid

A dietitian and doctor should give personalized advice, but some general principles apply.

1. Eat: energy-dense, high-protein foods such as eggs, dairy, legumes, fish and lean meat to support growth and immune-cell production, as tolerated. [79]

2. Eat: plenty of fruits and cooked vegetables to provide vitamins, minerals and fiber, while adjusting textures for swallowing or gut tolerance. Raw salads may be restricted in some neutropenic protocols. [80]

3. Eat: whole grains, potatoes and rice for steady energy, choosing low-fat cooking methods to reduce gastrointestinal discomfort. [81]

4. Eat: foods rich in vitamin D, calcium and omega-3s, such as fortified dairy products and oily fish, to support bones and immune regulation. [82]

5. Eat: safe, well-cooked foods prepared with strict kitchen hygiene, including separate chopping boards for raw meat and regular disinfection of surfaces. [83]

6. Avoid: raw or undercooked meat, eggs and fish (such as sushi, runny eggs or rare steak), which carry a high risk of bacterial or parasitic infection in immunodeficient patients. [84]

7. Avoid: unpasteurized milk, cheese or juices, and foods from unreliable street vendors where hygiene cannot be guaranteed. [85]

8. Avoid: buffet foods left at room temperature for a long time, as bacteria grow quickly in these conditions and may cause serious food-borne illness. [86]

9. Avoid: excessive sugar-sweetened drinks and highly processed foods, which add calories without nutrients and may worsen dental problems in children on long-term medicines. [87]

10. Avoid: herbal or “immune-boosting” supplements without medical approval, because some may interact with crucial drugs or be contaminated with microbes or heavy metals. [88]

---

Frequently asked questions (FAQs)

1. Is combined immunodeficiency due to GINS1 deficiency the same as classic SCID?
It belongs to the broader SCID/combined immunodeficiency spectrum, but it has its own genetic cause (GINS1 mutations) and a typical combination of NK-cell deficiency, chronic neutropenia and growth restriction. Management principles are similar to SCID, but details are guided by each patient’s immune profile. [89]

2. Can this disease be cured?
The only established curative option today is successful allogeneic HSCT from a well-matched donor, which replaces the defective blood-forming and immune system. Without HSCT, treatment focuses on preventing infections and supporting bone-marrow function, which can improve survival but does not correct the genetic defect. [90]

3. When is HSCT usually done?
Transplant teams prefer to do HSCT as early as possible, ideally before repeated severe infections or organ damage occur, because outcomes are best when patients are younger and in relatively good condition. The exact timing depends on donor availability, infection history and center experience. [91]

4. Why are neutrophils and NK cells so low in this condition?
Because GINS1 is part of the DNA-replication complex, bone-marrow precursor cells cannot divide normally. As a result, neutrophils and NK cells fail to mature and are produced in much smaller numbers, leading to chronic neutropenia and NK-cell deficiency in most affected children. [92]

5. How is the diagnosis confirmed?
Doctors combine clinical signs (recurrent infections, growth delay, cytopenias) with detailed immune tests (lymphocyte subsets, NK-cell counts, neutrophil counts) and genetic sequencing that shows disease-causing mutations in both copies of the GINS1 gene. Sometimes bone-marrow examination is performed to assess cell production. [93]

6. Do all patients look the same clinically?
No. Even with the same gene affected, severity can vary. Some children have very early, severe infections and profound cytopenias; others have slightly milder courses. Differences may relate to the exact mutation, other genes and environmental exposures. [94]

7. Why is IVIG so commonly used?
IVIG provides a broad mix of antibodies from healthy donors, helping to compensate for defective antibody responses and reduce the number and severity of bacterial and some viral infections. It is a core part of combined immunodeficiency management in many guidelines. [95]

8. Is long-term G-CSF safe?
Filgrastim and related G-CSF drugs are well-studied in congenital neutropenia and chemotherapy-induced neutropenia. They can significantly reduce infection rates but must be monitored for side effects such as bone pain, enlarged spleen and rare long-term marrow changes; dosing is always individualized. [96]

9. Can children with GINS1 deficiency go to school?
Many can attend school with careful infection-control measures, vaccination of classmates where possible and rapid access to medical care. Some families choose home schooling or blended approaches, especially before HSCT or during times of high community infection rates. [97]

10. Is physical exercise safe?
Gentle, supervised exercise is usually encouraged to maintain muscle strength, lung capacity and mental well-being, but intensity is adjusted around infections, anemia and fatigue. The medical team and physiotherapist can provide a personalized plan. [98]

11. Can parents have more children safely?
With genetic counselling, parents can learn their carrier status and recurrence risk. Options such as prenatal diagnosis or pre-implantation genetic testing may be considered to avoid future affected pregnancies, depending on local availability and family preferences. [99]

12. Are there new treatments being researched?
Research in SCID and related disorders is rapidly evolving, including gene-therapy approaches and better transplant strategies. For GINS1 deficiency specifically, data are still limited because it is extremely rare, but principles from other combined immunodeficiencies are being applied and refined over time. [100]

13. Does diet really make a difference?
Diet cannot correct the genetic defect, but good nutrition helps the body cope with infections, recover from hospital stays and tolerate HSCT. Malnutrition worsens immunity, so diet and supplements are key supportive therapies alongside medicines and procedures. [101]

14. Can complementary or herbal medicines be used?
Because many herbal products are unregulated, may carry microbes or toxins, and can interact with vital medicines like antifungals or immunosuppressants, they should only be used after full discussion with the treating team. In most cases, doctors prefer focusing on well-studied therapies. [102]

15. What is the long-term outlook?
Outlook depends on infection control, access to HSCT, and how early the disease is recognized. With modern supportive care and successful transplantation, some children can achieve good long-term survival and quality of life, but close lifelong follow-up is essential to manage late effects and protect the new immune system. [103]

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: February 13, 2025.